According to the latest market research report by Future Market Insights, the global neovascular age-related macular degeneration treatment market is poised for substantial growth, projected at a robust Compound Annual Growth Rate (CAGR) of 5% from 2023 to 2033. The market, valued at USD 3 billion in 2023, is anticipated to reach USD 4.89 billion …